Wolverine Asset Management’s Novavax NVAX Stock Holding History

Wolverine Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	+37,037	New	+$332K	﹤0.01%	1017
2024 Q1	–	Sell	-22,767	Closed	-$106K	–	1837
2023 Q4	$109K	Hold	22,767	–	–	﹤0.01%	1119
2023 Q3	$165K	Sell	22,767 -35,383	-61%	-$283K	﹤0.01%	1072
2023 Q2	$432K	Sell	58,150 -291,850	-83%	-$2.3M	0.01%	875
2023 Q1	$2.43M	Buy	+350,000	New	+$3.22M	0.03%	474
2022 Q4	–	Sell	-65,038	Closed	-$1.15M	–	2249
2022 Q3	$1.18M	Buy	+65,038	New	+$2.82M	0.01%	740
2021 Q3	–	Sell	-666	Closed	-$147K	–	2238
2021 Q2	$141K	Buy	+666	New	+$122K	﹤0.01%	1373
2020 Q4	–	Sell	-2,787	Closed	-$296K	–	1816
2020 Q3	$301K	Buy	+2,787	New	+$340K	﹤0.01%	870
2020 Q2	–	Sell	-7,437	Closed	-$284K	–	1706
2020 Q1	$100K	Sell	7,437 -6,995	-48%	-$59.2K	﹤0.01%	1046
2019 Q4	$57K	Buy	+14,432	New	+$62.6K	﹤0.01%	1172
2019 Q2	–	Sell	-4,256	Closed	-$33.5K	–	1553
2019 Q1	$46K	Buy	4,256 +576	+16%	+$18.2K	﹤0.01%	1190
2018 Q4	$135K	Buy	+3,680	New	+$143K	﹤0.01%	1310

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Wolverine Asset Management's NVAX Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in Novavax (NVAX) in Q2 2026: 37,037 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1017 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in NVAX as recently as Q4 2023.

Wolverine Asset Management first reported a position in NVAX in Q4 2018 and has held it in 12 quarters since. The position peaked at $2.43M in Q1 2023. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Wolverine Asset Management held 37,037 shares of Novavax worth $349K as of Q2 2026.
Novavax was a new Wolverine Asset Management position in Q2 2026.
Novavax made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1017 holding.
Wolverine Asset Management first reported a position in Novavax in Q4 2018 and has held it in 12 quarters since.
Wolverine Asset Management's Novavax position peaked at $2.43M in Q1 2023.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.